Sermonix Pharmaceuticals, Inc. — Form D

Sermonix Pharmaceuticals, Inc. of COLUMBUS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-23. The offering totals $40.2M, of which $40.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-11-23
• Form: D
• Accession: 0001655566-21-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $40.2M
• Amount sold: $40.2M
• Investors: 9
• Date of first sale: 2021-11-12
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-422178

Issuer

• Name: Sermonix Pharmaceuticals, Inc.
• CIK: 0001655566
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 3000 E. MAIN ST, COLUMBUS, OH, 43209
• Phone: (614) 864-4919

Officers, directors & promoters (17)

Other filings by this issuer (2)

More

• CIK 1655566 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search